Critics of MTII say it is largely unregulated and lacks standards for purity, sterility and dosing.
Not required for most people: If you are healthy aside from weight concerns, have no chronic conditions, are not taking other medications that interact with GLP-1s, and are tolerating treatment well, you may not benefit from routine lab testing
Oxidative stress leads to a host of diseases, from cancer to diabetes and from Alzheimers disease to stroke
The twice-weekly dosing schedule integrates easily with other peptide administrations
Product Specifications Compound: AOD-9604 Class: Synthetic peptide fragment / growth hormone C-terminal analog Origin: C-terminal fragment of human growth hormone (residues 177-191) with N-terminal tyrosine addition Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Weight: ~1815 Da Form: Lyophilized powder Vial Size: 5mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Context AOD-9604 is utilized in research applications involving peptide chemistry , growth hormone fragment research , and cellular research applications
T.Correa-CostaM.CastoldiA.FelizardoR
)
